What do we know about pathological mechanism and pattern of lung injury related to SARS-CoV-2 Omicron variant?

Autopsy Comorbidity Diffuse alveolar damage Immune escape process Lung injury Omicron Pathological pattern SARS-CoV-2 variants Ventilator-induced lung injury

Journal

Diagnostic pathology
ISSN: 1746-1596
Titre abrégé: Diagn Pathol
Pays: England
ID NLM: 101251558

Informations de publication

Date de publication:
10 Feb 2023
Historique:
received: 08 12 2022
accepted: 02 02 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

Pulmonary damage in SARS-CoV-2 is characterized pathologically by diffuse alveolar damage (DAD) and thrombosis. In addition, nosocomial bacterial superinfections and ventilator-induced lung injury (VILI) are likely to occur. The SARS-CoV-2 Omicron variant have manifested itself as a more diffusive virus which mainly affects the upper airways, such as the nose and pharynx. The mechanism leading to a lung injury with a complex clinical course for the Omicron SARS-CoV-2 variant remains unclear. A key question is whether the organ damage is due to direct organ targeting of the virus or downstream effects such as an altered immune response. An immune escape process of Omicron variant is being studied, which could lead to prolonged viral shedding and increase hospitalization times in patients with comorbidities, with an increased risk of pulmonary co-infections/superinfections and organ damage. This brief commentary reports the current knowledge on the Omicron variant and provides some useful suggestions to the scientific community.

Identifiants

pubmed: 36765347
doi: 10.1186/s13000-023-01306-y
pii: 10.1186/s13000-023-01306-y
pmc: PMC9911937
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

18

Informations de copyright

© 2023. The Author(s).

Références

Front Public Health. 2022 Dec 22;10:1032957
pubmed: 36620263
J Virol. 2022 Apr 27;96(8):e0012822
pubmed: 35343766
Front Immunol. 2022 Feb 09;13:801522
pubmed: 35222380
Radiology. 2023 Jan;306(1):261-269
pubmed: 35727150
Nat Microbiol. 2022 Aug;7(8):1161-1179
pubmed: 35798890
Int J Infect Dis. 2022 Dec 27;128:51-57
pubmed: 36584746
Nat Microbiol. 2022 Aug;7(8):1114-1115
pubmed: 35821416
J Infect Public Health. 2023 Feb;16(2):182-189
pubmed: 36566602
BMJ. 2021 Nov 29;375:n2943
pubmed: 34845008
Nat Chem Biol. 2022 Sep;18(9):963-971
pubmed: 35676539
Cell Rep Med. 2022 Jun 21;3(6):100651
pubmed: 35654046
Int J Environ Res Public Health. 2022 Apr 19;19(9):
pubmed: 35564325
EBioMedicine. 2022 Sep;83:104193
pubmed: 35930888
JCI Insight. 2022 Aug 22;7(16):
pubmed: 35852866
Cell. 2022 Mar 17;185(6):1041-1051.e6
pubmed: 35202566
Clin Pathol. 2022 Mar 4;15:2632010X221083223
pubmed: 35284825
Nature. 2022 Jan;601(7892):177
pubmed: 34987210
Virchows Arch. 2022 Aug;481(2):139-159
pubmed: 35364700

Auteurs

Roberto Scendoni (R)

Department of Law, Institute of Legal Medicine, University of Macerata, Piaggia Dell'Università, 2, 62100, Macerata, Italy. r.scendoni@unimc.it.

Mariano Cingolani (M)

Department of Law, Institute of Legal Medicine, University of Macerata, Piaggia Dell'Università, 2, 62100, Macerata, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH